title: Inoperable esophageal cancer and outcome of palliative care.
abstract: OBJECTIVE
  To determine the outcome of esophageal cancer patients referred for palliative care, in Gorgan and Gonbad gastrointestinal clinics, northeast of Iran.
  
  
  METHODS
  This cross-sectional study was done on inoperable esophageal cancer cases referred to gastrointestinal clinics in Gorgan and Gonbad city (2005-2006). Demographic data were collected during the procedure and cases were followed up every one month. Improvement proportion was calculated with 95% confidence interval, to determine the rate of improvement. Survival analysis and Kaplan-Meier methods were used to estimate the duration of palliative care effectiveness.
  
  
  RESULTS
  We recruited 39 cases into the study. Squamous cell carcinoma was the most prevalent (92.3%). The middle third of the esophagus was involved predominantly (51.3%). Dilation was the most preferred method (89.7%) and stenting was done in 4 cases. Decreasing dysphagia score was not related to palliation method or pathology type of carcinoma. Age of the patients was significantly related to the improvement of dysphagia score. Mean survival time was 137.6 d and median was 103 d.
  
  
  CONCLUSIONS
  Results of this study showed a low survival rate after palliative care in esophageal cancer cases despite dysphagia scores' improvement after dilating or stenting.
authors.affiliation: Golestan University of Medical Sciences, Golestan Research center of Gastroenterology and Hepatology, Gorgan 49177-65181, Iran.
authors.forename: Sima
authors.initials: S
authors.lastname: Besharat
authors.forename: Ali
authors.initials: A
authors.lastname: Jabbari
authors.forename: Shahryar
authors.initials: S
authors.lastname: Semnani
authors.forename: Abbasali
authors.initials: A
authors.lastname: Keshtkar
authors.forename: Jeran
authors.initials: J
authors.lastname: Marjani
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000401:mortality / Q000628:therapy*; D003430:Cross-Sectional Studies; D003680:Deglutition Disorders / Q000209:etiology / Q000628:therapy*; D004106:Dilatation; D004938:Esophageal Neoplasms / Q000150:complications / Q000401:mortality / Q000628:therapy*; D005260:Female; D006801:Humans; D007492:Iran; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011788:Quality of Life; D012720:Severity of Illness Index; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome